Chris Pasquale
Stock Analyst at Guggenheim
(0.39)
# 4,133
Out of 4,948 analysts
4
Total ratings
n/a
Success rate
-9.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZIMV ZimVie | Initiates: Neutral | n/a | $18.85 | - | 1 | Mar 18, 2022 | |
| DXCM DexCom | Upgrades: Buy | $145 | $80.95 | +79.12% | 1 | Jan 7, 2022 | |
| COO The Cooper Companies | Upgrades: Buy | $124 | $73.26 | +68.92% | 1 | Jan 3, 2022 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $45 | $41.59 | +8.20% | 1 | Oct 11, 2021 |
ZimVie
Mar 18, 2022
Initiates: Neutral
Price Target: n/a
Current: $18.85
Upside: -
DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $80.95
Upside: +79.12%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $73.26
Upside: +68.92%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $41.59
Upside: +8.20%